An overview of the structure and function of thrombin

Seminars in Thrombosis and Hemostasis

Volumn 32, Issue SUPPL. 1, 2006, Pages 3-15

  Davie, Earl W ^a   Kulman, John D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Antithrombin; Blood coagulation; Prothrombin; Serine protease; Thrombin

Indexed keywords

AMINO ACID; ANTITHROMBIN; MITOGENIC AGENT; NUCLEOTIDE; PROTHROMBIN; SERINE PROTEINASE; THROMBIN;

AMINO ACID SEQUENCE; BLOOD CLOTTING; BLOOD VESSEL INJURY; CATALYSIS; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; HEMOSTASIS; HUMAN; MACROMOLECULE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SEQUENCE ALIGNMENT; STRUCTURE ANALYSIS; THROMBOCYTE AGGREGATION;

ANIMALS; BINDING SITES; HEMOSTASIS; HUMANS; SEQUENCE ALIGNMENT; SERINE ENDOPEPTIDASES; THROMBIN;

EID: 33646470969     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-939550     Document Type: Review

References (100)

1. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989;134:1087-1097
2. Fleck RA, Rao LV, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990;59:421-437
3. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991;30:10363-10370
4. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005;3:1894-1904
5. Lorand L. Physiological roles of fibrinogen and fibrin. Fed Proc 1965;24:784-793
6. Chen R, Doolittle RF. Cross-linking sites in human and bovine fibrin. Biochemistry 1971;10:4487-4491
7. Chen R, Doolittle RF. Identification of the polypeptide chains involved in the cross-linking of fibrin. Proc Natl Acad Sci USA 1969;63:420-427
8. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 1995;270:14477-14484
9. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 1991;266:7353-7358
10. Vehar GA, Davie EW. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 1980;19:401-410
11. Fulcher CA, Roberts JR, Zimmerman TS. Thrombin proteolysis of purified factor VIII procoagulant protein: correlation of activation with generation of a specific polypeptide. Blood 1983;61:807-811
12. Esmon CT. The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. J Biol Chem 1979;254:964-973
13. Nesheim ME, Mann KG. Thrombin-catalyzed activation of single chain bovine factor V. J Biol Chem 1979;254:1326-1334
14. Suzuki K, Dahlbäck B, Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982;257:6556-6564
15. Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982;122:429-436
16. Majerus PW, Miletich JP. Relationships between platelets and coagulation factors in hemostasis. Annu Rev Med 1978;29:41-49
17. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057-1068
18. Kahn ML, Zheng YW, Huang W, et al. A dual thrombin receptor system for platelet activation. Nature 1998;394:690-694
19. Xu WF, Andersen H, Whitmore TE, et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998;95:6642-6646
20. De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem 2001;276:4692-4698
21. Adam F, Guillin MC, Jandrot-Perrus M. Glycoprotein Ib-mediated platelet activation. A signalling pathway triggered by thrombin. Eur J Biochem 2003;270:2959-2970
22. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989;264:4743-4746
23. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258-264
24. Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989;264:7768-7771
25. Daniel TO, Gibbs VC, Milfay DF, Garovoy MR, Williams LT. Thrombin stimulates c-sis gene expression in microvascular endothelial cells. J Biol Chem 1986;261:9579-9582
26. Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol 1994;144:975-985
27. Kranzhofer R, Clinton SK, Ishii K, Coughlin SR, Fenton JW II, Libby P. Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. Circ Res 1996;79:286-294
28. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW II, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993;91:94-98
29. Chen LB, Buchanan JM. Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc Natl Acad Sci USA 1975;72:131-135
30. Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973;248:6490-6505
31. Tollefsen DM, Majerus DW, Blank MK. Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. J Biol Chem 1982;257:2162-2169
32. Baker JB, Low DA, Simmer RL, Cunningham DD. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 1980;21:37-45
33. Bagdy D, Barabas E, Graf L, Petersen TE, Magnusson S. Hirudin. Methods Enzymol 1976;45:669-678
34. Strube KH, Kroger B, Bialojan S, Otte M, Dodt J. Isolation, sequence analysis, and cloning of haemadin. An anticoagulant peptide from the Indian leech. J Biol Chem 1993;268:8590-8595
35. Friedrich T, Kroger B, Bialojan S, et al. A Kazal-type inhibitor with thrombin specificity from Rhodnius prolixus. J Biol Chem 1993;268:16216-16222
36. Butkowski RJ, Elion J, Downing MR, Mann KG. Primary structure of human prethrombin 2 and alpha-thrombin. J Biol Chem 1977;252:4942-4957
37. Magnusson S, Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE. Proceedings: Complete primary structure of prothrombin. Partial primary structures of plasminogen and hirudin. Thromb Diath Haemorrh 1975;34:562-563
38. MacGillivray RT, Degen SJ, Chandra T, Woo SL, Davie EW. Cloning and analysis of a cDNA coding for bovine prothrombin. Proc Natl Acad Sci USA 1980;77:5153-5157
39. Degen SJ, MacGillivray RT, Davie EW. Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. Biochemistry 1983;22:2087-2097
40. MacGillivray RT, Davie EW. Characterization of bovine prothrombin mRNA and its translation product. Biochemistry 1984;23:1626-1634
41. Degen SJ, Davie EW. Nucleotide sequence of the gene for human prothrombin. Biochemistry 1987;26:6165-6177
42. Foster DC, Rudinski MS, Schach BG, et al. Propeptide of human protein C is necessary for gamma-carboxylation. Biochemistry 1987;26:7003-7011
43. Wu SM, Cheung WF, Frazier D, Stafford DW. Cloning and expression of the cDNA for human gamma-glutamyl carboxylase. Science 1991;254:1634-1636
44. Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA 1974;71:2730-2733
45. Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem 1974;249:6347-6350
46. Hansson K, Stenflo J. Post-translational modifications in proteins involved in blood coagulation. J Thromb Haemost 2005;3:2633-2648
47. Sadowski JA, Esmon CT, Suttie JW. Vitamin K-dependent carboxylase. Requirements of the rat liver microsomal enzyme system. J Biol Chem 1976;251:2770-2776
48. Cain D, Hutson SM, Wallin R. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane. J Biol Chem 1997;272:29068-29075
49. Fasco MJ, Principe LM. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system. Biochem Biophys Res Commun 1980;97:1487-1492
50. MacNicoll AD, Nadian AK, Townsend MG. Inhibition by warfarin of liver microsomal vitamin K-reductase in warfarin-resistant and susceptible rats. Biochem Pharmacol 1984;33:1331-1336
51. Ren P, Stark PY, Johnson RL, Bell RG. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide. J Pharmacol Exp Ther 1977;201:541-546
52. Stenflo J. Vitamin K and the biosynthesis of prothrombin. IV. Isolation of peptides containing prosthetic groups from normal prothrombin and the corresponding peptides from dicoumarol-induced prothrombin. J Biol Chem 1974;249:5527-5535
53. Mizuochi T, Yamashita K, Fujikawa K, Kisiel W, Kobata A. The carbohydrate of bovine prothrombin. Occurrence of Gal beta 1 leads to 3GlcNAc grouping in asparagine-linked sugar chains. J Biol Chem 1979;254:6419-6425
54. Mizuochi T, Fujii J, Kisiel W, Kobata A. Studies on the structures of the carbohydrate moiety of human prothrombin. J Biochem (Tokyo) 1981;90:1023-1031
55. Nilsson B, Horne MK III, Gralnick HR. The carbohydrate of human thrombin: structural analysis of glycoprotein oligosaccharides by mass spectrometry. Arch Biochem Biophys 1983;224:127-133
56. Nesheim ME, Taswell JB, Mann KG. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem 1979;254:10952-10962
57. Krishnaswamy S, Church WR, Nesheim ME, Mann KG. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J Biol Chem 1987;262:3291-3299
58. Brufatto N, Nesheim ME. Analysis of the kinetics of prothrombin activation and evidence that two equilibrating forms of prothrombinase are involved in the process. J Biol Chem 2003;278:6755-6764
59. Fenton JW II, Fasco MJ, Stackrow AB. Human thrombins. Production, evaluation, and properties of alpha-thrombin. J Biol Chem 1977;252:3587-3598
60. Gorman JJ, Castaldi PA, Shaw DC. The structure of human thrombin in relation to autolytic degradation. Biochim Biophys Acta 1976;439:1-16
61. Boissel JP, Le Bonniec B, Rabiet MJ, Labie D, Elion J. Covalent structures of beta and gamma autolytic derivatives of human alpha-thrombin. J Biol Chem 1984;259:5691-5697
62. Berliner LJ. Structure-function relationships in human alpha- and gamma-thrombins. Mol Cell Biochem 1984;61:159-172
63. Lundblad RL, Noyes CM, Mann KG, Kingdon HS. The covalent differences between bovine alpha- and beta-thrombin. A structural explanation for the changes in catalytic activity. J Biol Chem 1979;254:8524-8528
64. Hofsteenge J, Braun PJ, Stone SR. Enzymatic properties of proteolytic derivatives of human alpha-thrombin. Biochemistry 1988;27:2144-2151
65. Banfield DK, MacGillivray RT. Partial characterization of vertebrate prothrombin cDNAs: amplification and sequence analysis of the B chain of thrombin from nine different species. Proc Natl Acad Sci USA 1992;89:2779-2783
66. Kraut J. Serine proteases: structure and mechanism of catalysis. Annu Rev Biochem 1977;46:331-358
67. Fehlhammer H, Bode W, Huber R. Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. J Mol Biol 1977;111:415-438
68. Bode W, Turk D, Karshikov A. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci 1992;1:426-471
69. Stubbs MT, Bode W. The clot thickens: clues provided by thrombin structure. Trends Biochem Sci 1995;20:23-28
70. Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 1989;8:3467-3475
71. Lottenberg R, Hall JA, Blinder M, Binder EP, Jackson CM. The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions. Biochim Biophys Acta 1983;742:539-557
72. Le Bonniec BF, MacGillivray RT, Esmon CT. Thrombin Glu-39 restricts the P′3 specificity to nonacidic residues. J Biol Chem 1991;266:13796-13803
73. Le Bonniec BF, Myles T, Johnson T, Knight CG, Tapparelli C, Stone SR. Characterization of the P2′ and P3′ specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis. Biochemistry 1996;35:7114-7122
74. Marque PE, Spuntarelli R, Juliano L, Aiach M, Le Bonniec BF. The role of Glu(192) in the allosteric control of the S(2)′ and S(3)′ subsites of thrombin. J Biol Chem 2000;275:809-816
75. Backes BJ, Harris JL, Leonetti F, Craik CS, Ellman JA. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nat Biotechnol 2000;18:187-193
76. Bianchini EP, Louvain VB, Marque PE, Juliano MA, Juliano L, Le Bonniec BF. Mapping of the catalytic groove preferences of factor Xa reveals an inadequate selectivity for its macromolecule substrates. J Biol Chem 2002;277:20527-20534
77. Le Bonniec BF, Guinto ER, MacGillivray RT, Stone SR, Esmon CT. The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors. J Biol Chem 1993;268:19055-19061
78. Dang QD, Sabetta M, Di Cera E. Selective loss of fibrinogen clotting in a loop-less thrombin. J Biol Chem 1997;272:19649-19651
79. Le Bonniec BF, Guinto ER, Esmon CT. Interaction of thrombin des-ETW with antithrombin III, the Kunitz inhibitors, thrombomodulin and protein C. Structural link between the autolysis loop and the Tyr-Pro-Pro-Trp insertion of thrombin. J Biol Chem 1992;267:19341-19348
80. Di Cera E, Guinto ER, Vindigni A, et al. The Na+ binding site of thrombin. J Biol Chem 1995;270:22089-22092
81. Pineda AO, Carrell CJ, Bush LA, et al. Molecular dissection of Na+ binding to thrombin. J Biol Chem 2004;279:31842-31853
82. Krem MM, Cera ED. Evolution of enzyme cascades from embryonic development to blood coagulation. Trends Biochem Sci 2002;27:67-74
83. Krem MM, Di Cera E. Molecular markers of serine protease evolution. EMBO J 2001;20:3036-3045
84. Tsiang M, Jain AK, Dunn KE, Rojas ME, Leung LL, Gibbs CS. Functional mapping of the surface residues of human thrombin. J Biol Chem 1995;270:16854-16863
85. Pechik I, Madrazo J, Mosesson MW, Hernandez I, Gilliland GL, Medved L. Crystal structure of the complex between thrombin and the central "E" region of fibrin. Proc Natl Acad Sci USA 2004;101:2718-2723
86. Mathews II, Padmanabhan KP, Ganesh V, et al. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry 1994;33:3266-3279
87. Esmon CT, Lollar P. Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII. J Biol Chem 1996;271:13882-13887
88. Myles T, Yun TH, Hall SW, Leung LL. An extensive interaction interface between thrombin and factor V is required for factor V activation. J Biol Chem 2001;276:25143-25149
89. Myles T, Yun TH, Leung LL. Structural requirements for the activation of human factor VIII by thrombin. Blood 2002;100:2820-2826
90. Fuentes-Prior P, Iwanaga Y, Huber R, et al. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 2000;404:518-525
91. Ye J, Liu LW, Esmon CT, Johnson AE. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity. J Biol Chem 1992;267:11023-11028
92. De Cristofaro R, De Candia E, Landolfi R, Rutella S, Hall SW. Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib. Biochemistry 2001;40:13268-13273
93. Sheehan JP, Wu Q, Tollefsen DM, Sadler JE. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity. J Biol Chem 1993;268:3639-3645
94. Stone SR, Braun PJ, Hofsteenge J. Identification of regions of alpha-thrombin involved in its interaction with hirudin. Biochemistry 1987;26:4617-4624
95. Rydel TJ, Tulinsky A, Bode W, Huber R. Refined structure of the hirudin-thrombin complex. J Mol Biol 1991;221:583-601
96. Rydel TJ, Ravichandran KG, Tulinsky A, et al. The structure of a complex of recombinant hirudin and human alpha-thrombin. Science 1990;249:277-280
97. Li W, Johnson DJ, Esmon CT, Huntington JA. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol 2004;11:857-862
98. Dumas JJ, Kumar R, Seehra J, Somers WS, Mosyak L. Crystal structure of the GpIb alpha-thrombin complex essential for platelet aggregation. Science 2003;301:222-226
99. Richardson JL, Kroger B, Hoeffken W, et al. Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. EMBO J 2000;19:5650-5660
100. Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605-1612